The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(6,8-Dimethylimidazo[1,2-a]pyrazin-2-yl)-4-(4-methylpiperazin-1-yl)benzamide ID: ALA4081789
PubChem CID: 137647660
Max Phase: Preclinical
Molecular Formula: C20H24N6O
Molecular Weight: 364.45
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cn2cc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)nc2c(C)n1
Standard InChI: InChI=1S/C20H24N6O/c1-14-12-26-13-18(22-19(26)15(2)21-14)23-20(27)16-4-6-17(7-5-16)25-10-8-24(3)9-11-25/h4-7,12-13H,8-11H2,1-3H3,(H,23,27)
Standard InChI Key: TVJPLGCKQZRBMI-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
29.1784 -18.3463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9357 -18.6785 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2626 -17.5261 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.0696 -17.3480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4785 -18.0621 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.3001 -18.0618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7136 -17.3483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2956 -16.6334 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.4753 -16.6371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0622 -15.9274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5392 -17.3466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4640 -18.7589 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.7474 -18.3500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0330 -18.7626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3198 -18.3540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6100 -18.7658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6117 -19.5921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3290 -20.0050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0401 -19.5866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9003 -20.0114 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.1834 -19.5972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4716 -20.0113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4706 -20.8371 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.1876 -21.2473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9054 -20.8355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7552 -21.2480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7453 -17.5246 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 5 1 0
4 3 2 0
3 1 1 0
4 5 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
9 10 1 0
7 11 1 0
1 12 1 0
12 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
20 21 1 0
20 25 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
17 20 1 0
23 26 1 0
13 27 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 364.45Molecular Weight (Monoisotopic): 364.2012AlogP: 2.35#Rotatable Bonds: 3Polar Surface Area: 65.77Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.74CX LogP: 1.45CX LogD: 0.94Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.77Np Likeness Score: -1.47
References 1. Pinard E, Green L, Reutlinger M, Weetall M, Naryshkin NA, Baird J, Chen KS, Paushkin SV, Metzger F, Ratni H.. (2017) Discovery of a Novel Class of Survival Motor Neuron 2 Splicing Modifiers for the Treatment of Spinal Muscular Atrophy., 60 (10): [PMID:28441483 ] [10.1021/acs.jmedchem.7b00406 ]